GLCGX
Price
$30.43
Change
-$0.40 (-1.30%)
Updated
Jun 13 closing price
Net Assets
1.45B
RGEBX
Price
$74.89
Change
-$0.91 (-1.20%)
Updated
Jun 13 closing price
Net Assets
306.22B
Interact to see
Advertisement

GLCGX vs RGEBX

Header iconGLCGX vs RGEBX Comparison
Open Charts GLCGX vs RGEBXBanner chart's image
Goldman Sachs Large Cap Gr Insghts A
Price$30.43
Change-$0.40 (-1.30%)
VolumeN/A
Net Assets1.45B
American Funds Growth Fund of Amer R2E
Price$74.89
Change-$0.91 (-1.20%)
VolumeN/A
Net Assets306.22B
GLCGX vs RGEBX Comparison Chart
Loading...
View a ticker or compare two or three
VS
GLCGX vs. RGEBX commentary
Jun 15, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is GLCGX is a Buy and RGEBX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
RGEBX has more cash in the bank: 306B vs. GLCGX (1.45B). GLCGX (0.00) and RGEBX (0.00) have matching dividends . GLCGX was incepted earlier than RGEBX: GLCGX (28 years) vs RGEBX (11 years). RGEBX (1.09) is less costly to investors than GLCGX (0.95). GLCGX is a more actively managed with annual turnover of: 215.00 vs. RGEBX (25.00). RGEBX has a lower initial minimum investment than GLCGX: RGEBX (250) vs GLCGX (1000). RGEBX annual gain was more profitable for investors over the last year : 7.68 vs. GLCGX (0.46). RGEBX return over 5 years is better than : 45.42 vs. GLCGX (-9.16).
GLCGXRGEBXGLCGX / RGEBX
Total Expense Ratio0.921.0984%
Annual Report Gross Expense Ratio0.951.0987%
Fund Existence28 years11 years-
Gain YTD-1.4254.829-30%
Front Load6%N/A-
Min. Initial Investment1000250400%
Min. Initial Investment IRAN/AN/A-
Net Assets1.45B306B0%
Annual Yield % from dividends0.000.00-
Returns for 1 year0.467.686%
Returns for 3 years26.5951.0152%
Returns for 5 years-9.1645.42-20%
Returns for 10 years35.5565.8754%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
APGE44.482.62
+6.26%
Apogee Therapeutics
VVOS2.140.01
+0.47%
Vivos Therapeutics
SJM95.72-1.65
-1.69%
JM Smucker Company (The)
ELVA3.38-0.17
-4.79%
Electrovaya
NNDM1.44-0.12
-7.69%
Nano Dimension Ltd